Clinical Trial Detail

NCT ID NCT02540876
Title Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Chicago
Indications

Advanced Solid Tumor

Therapies

ABT-348

Age Groups: adult

Additional content available in CKB BOOST